Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study

Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study

Abstract Background Beta-lactams (i.e., penicillins, cephalosporins, carbapenems, monobactams) are the most widely used class of antibiotics in critically ill patients. There is substantial interpatient variability in beta-lactam pharmacokinetics which renders their effectiveness and safety largely...

Full description

Bibliographic Details
Main Authors: Erin F. Barreto, Andrew D. Rule, Mohammad H. Alshaer, Jason A. Roberts, Mohd Hafiz Abdul Aziz, Marc H. Scheetz, Kristin C. Mara, Paul J. Jannetto, Ognjen Gajic, John C. O’Horo, Kasey R. Boehmer
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Implementation Science Communications
Subjects:
Study protocol
Mixed-methods
Implementation
Therapeutic drug monitoring
Beta-lactams
Pharmacokinetics/pharmacodynamics
Online Access:https://doi.org/10.1186/s43058-021-00134-9

Internet

https://doi.org/10.1186/s43058-021-00134-9

Similar Items